SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'ME8'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FFY_A_MRCA1993_1 (ISOLEUCYL-TRNASYNTHETASE) |
3kfl | METHIONYL-TRNASYNTHETASE (Leishmaniamajor) | 5 / 12 | HIS A 225GLY A 227GLY A 484ASP A 486HIS A 513 | POP A 802 ( 4.0A)ME8 A 801 (-3.4A)ME8 A 801 (-3.2A)ME8 A 801 ( 2.6A)ME8 A 801 (-4.6A) | 0.80A | 1ffyA-3kflA:21.6 | 1ffyA-3kflA:21.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FFY_A_MRCA1993_1 (ISOLEUCYL-TRNASYNTHETASE) |
3kfl | METHIONYL-TRNASYNTHETASE (Leishmaniamajor) | 5 / 12 | HIS A 228GLY A 227GLY A 484ASP A 486HIS A 513 | POP A 802 ( 3.8A)ME8 A 801 (-3.4A)ME8 A 801 (-3.2A)ME8 A 801 ( 2.6A)ME8 A 801 (-4.6A) | 1.05A | 1ffyA-3kflA:21.6 | 1ffyA-3kflA:21.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FFY_A_MRCA1993_1 (ISOLEUCYL-TRNASYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 5 / 12 | GLY A 20GLY A 261ASP A 263HIS A 290PHE A 292 | ME8 A 801 (-3.6A)ME8 A 801 (-2.9A)ME8 A 801 (-3.1A)ME8 A 801 (-4.7A)ME8 A 801 (-4.9A) | 0.61A | 1ffyA-6ax8A:23.3 | 1ffyA-6ax8A:6.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FFY_A_MRCA1993_1 (ISOLEUCYL-TRNASYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 5 / 12 | HIS A 18GLY A 20GLY A 261ASP A 263HIS A 290 | ME8 A 801 (-3.8A)ME8 A 801 (-3.6A)ME8 A 801 (-2.9A)ME8 A 801 (-3.1A)ME8 A 801 (-4.7A) | 0.55A | 1ffyA-6ax8A:23.3 | 1ffyA-6ax8A:6.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FFY_A_MRCA1993_1 (ISOLEUCYL-TRNASYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 5 / 12 | HIS A 21GLY A 20GLY A 261ASP A 263HIS A 290 | ME8 A 801 (-4.3A)ME8 A 801 (-3.6A)ME8 A 801 (-2.9A)ME8 A 801 (-3.1A)ME8 A 801 (-4.7A) | 1.28A | 1ffyA-6ax8A:23.3 | 1ffyA-6ax8A:6.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PG2_A_ADNA552_1 (METHIONYL-TRNASYNTHETASE) |
3kfl | METHIONYL-TRNASYNTHETASE (Leishmaniamajor) | 7 / 11 | HIS A 225GLY A 227HIS A 228GLY A 484ASP A 486ILE A 487HIS A 513 | POP A 802 ( 4.0A)ME8 A 801 (-3.4A)POP A 802 ( 3.8A)ME8 A 801 (-3.2A)ME8 A 801 ( 2.6A)ME8 A 801 (-4.0A)ME8 A 801 (-4.6A) | 0.66A | 1pg2A-3kflA:35.5 | 1pg2A-3kflA:26.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PG2_A_ADNA552_1 (METHIONYL-TRNASYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 9 / 11 | ALA A 9HIS A 18GLY A 20HIS A 21GLU A 24GLY A 261ASP A 263ILE A 264HIS A 290 | ME8 A 801 ( 3.8A)ME8 A 801 (-3.8A)ME8 A 801 (-3.6A)ME8 A 801 (-4.3A)ME8 A 801 (-3.6A)ME8 A 801 (-2.9A)ME8 A 801 (-3.1A)ME8 A 801 (-4.1A)ME8 A 801 (-4.7A) | 0.44A | 1pg2A-6ax8A:39.3 | 1pg2A-6ax8A:8.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PG2_A_ADNA552_1 (METHIONYL-TRNASYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 6 / 11 | GLY A 20HIS A 18GLY A 261ASP A 263ILE A 264HIS A 290 | ME8 A 801 (-3.6A)ME8 A 801 (-3.8A)ME8 A 801 (-2.9A)ME8 A 801 (-3.1A)ME8 A 801 (-4.1A)ME8 A 801 (-4.7A) | 1.14A | 1pg2A-6ax8A:39.3 | 1pg2A-6ax8A:8.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QU2_A_MRCA1993_1 (ISOLEUCYL-TRNASYNTHETASE) |
3kfl | METHIONYL-TRNASYNTHETASE (Leishmaniamajor) | 6 / 12 | HIS A 225GLY A 227HIS A 228GLY A 484ASP A 486HIS A 513 | POP A 802 ( 4.0A)ME8 A 801 (-3.4A)POP A 802 ( 3.8A)ME8 A 801 (-3.2A)ME8 A 801 ( 2.6A)ME8 A 801 (-4.6A) | 0.83A | 1qu2A-3kflA:21.7 | 1qu2A-3kflA:21.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QU2_A_MRCA1993_1 (ISOLEUCYL-TRNASYNTHETASE) |
3kfl | METHIONYL-TRNASYNTHETASE (Leishmaniamajor) | 5 / 12 | HIS A 228GLY A 227GLY A 484ASP A 486HIS A 513 | POP A 802 ( 3.8A)ME8 A 801 (-3.4A)ME8 A 801 (-3.2A)ME8 A 801 ( 2.6A)ME8 A 801 (-4.6A) | 1.05A | 1qu2A-3kflA:21.7 | 1qu2A-3kflA:21.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QU2_A_MRCA1993_1 (ISOLEUCYL-TRNASYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 6 / 12 | GLY A 20HIS A 18GLY A 261ASP A 263HIS A 290PHE A 292 | ME8 A 801 (-3.6A)ME8 A 801 (-3.8A)ME8 A 801 (-2.9A)ME8 A 801 (-3.1A)ME8 A 801 (-4.7A)ME8 A 801 (-4.9A) | 1.09A | 1qu2A-6ax8A:23.3 | 1qu2A-6ax8A:6.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QU2_A_MRCA1993_1 (ISOLEUCYL-TRNASYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 6 / 12 | GLY A 20HIS A 21GLY A 261ASP A 263HIS A 290PHE A 292 | ME8 A 801 (-3.6A)ME8 A 801 (-4.3A)ME8 A 801 (-2.9A)ME8 A 801 (-3.1A)ME8 A 801 (-4.7A)ME8 A 801 (-4.9A) | 0.54A | 1qu2A-6ax8A:23.3 | 1qu2A-6ax8A:6.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QU2_A_MRCA1993_1 (ISOLEUCYL-TRNASYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 6 / 12 | HIS A 18GLY A 20HIS A 21GLY A 261ASP A 263HIS A 290 | ME8 A 801 (-3.8A)ME8 A 801 (-3.6A)ME8 A 801 (-4.3A)ME8 A 801 (-2.9A)ME8 A 801 (-3.1A)ME8 A 801 (-4.7A) | 0.52A | 1qu2A-6ax8A:23.3 | 1qu2A-6ax8A:6.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QU3_A_MRCA993_1 (ISOLEUCYL-TRNASYNTHETASE) |
3kfl | METHIONYL-TRNASYNTHETASE (Leishmaniamajor) | 5 / 12 | HIS A 225GLY A 227HIS A 228ASP A 486HIS A 513 | POP A 802 ( 4.0A)ME8 A 801 (-3.4A)POP A 802 ( 3.8A)ME8 A 801 ( 2.6A)ME8 A 801 (-4.6A) | 1.04A | 1qu3A-3kflA:16.0 | 1qu3A-3kflA:21.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QU3_A_MRCA993_1 (ISOLEUCYL-TRNASYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 5 / 12 | GLY A 20HIS A 18ASP A 263HIS A 290PHE A 292 | ME8 A 801 (-3.6A)ME8 A 801 (-3.8A)ME8 A 801 (-3.1A)ME8 A 801 (-4.7A)ME8 A 801 (-4.9A) | 1.32A | 1qu3A-6ax8A:27.5 | 1qu3A-6ax8A:6.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QU3_A_MRCA993_1 (ISOLEUCYL-TRNASYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 5 / 12 | GLY A 20HIS A 21ASP A 263HIS A 290PHE A 292 | ME8 A 801 (-3.6A)ME8 A 801 (-4.3A)ME8 A 801 (-3.1A)ME8 A 801 (-4.7A)ME8 A 801 (-4.9A) | 0.64A | 1qu3A-6ax8A:27.5 | 1qu3A-6ax8A:6.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QU3_A_MRCA993_1 (ISOLEUCYL-TRNASYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 5 / 12 | HIS A 18GLY A 20HIS A 21ASP A 263HIS A 290 | ME8 A 801 (-3.8A)ME8 A 801 (-3.6A)ME8 A 801 (-4.3A)ME8 A 801 (-3.1A)ME8 A 801 (-4.7A) | 0.62A | 1qu3A-6ax8A:27.5 | 1qu3A-6ax8A:6.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QZR_B_CDXB901_1 (DNA TOPOISOMERASE II) |
3kfl | METHIONYL-TRNASYNTHETASE (Leishmaniamajor) | 4 / 7 | HIS A 470TYR A 451ASN A 449LEU A 309 | NoneNoneME8 A 801 (-4.6A)None | 1.13A | 1qzrA-3kflA:undetectable | 1qzrA-3kflA:21.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2KUH_A_HLTA150_1 (CALMODULIN) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 4 / 6 | MET A 407LEU A 327GLU A 24MET A 259 | NoneNoneME8 A 801 (-3.6A)None | 1.02A | 2kuhA-6ax8A:undetectable | 2kuhA-6ax8A:20.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QEO_A_LNRA200_1 (D7R4 PROTEIN) |
3kfl | METHIONYL-TRNASYNTHETASE (Leishmaniamajor) | 5 / 12 | TYR A 218HIS A 491ILE A 487VAL A 483MET A 295 | ME8 A 801 (-4.7A)ME8 A 801 (-4.6A)ME8 A 801 (-4.0A)NoneNone | 1.00A | 2qeoA-3kflA:undetectable | 2qeoA-3kflA:13.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VL2_B_BEZB1162_0 (PEROXIREDOXIN-5) |
3kfl | METHIONYL-TRNASYNTHETASE (Leishmaniamajor) | 4 / 7 | THR A 215PRO A 216PHE A 288THR A 255 | NoneME8 A 801 (-4.4A)NoneNone | 0.98A | 2vl2B-3kflA:3.4 | 2vl2B-3kflA:17.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X1L_A_ADNA601_1 (METHIONYL-TRNASYNTHETASE) |
3kfl | METHIONYL-TRNASYNTHETASE (Leishmaniamajor) | 7 / 11 | HIS A 225GLY A 227HIS A 228GLY A 484ASP A 486ILE A 487HIS A 513 | POP A 802 ( 4.0A)ME8 A 801 (-3.4A)POP A 802 ( 3.8A)ME8 A 801 (-3.2A)ME8 A 801 ( 2.6A)ME8 A 801 (-4.0A)ME8 A 801 (-4.6A) | 0.52A | 2x1lA-3kflA:45.3 | 2x1lA-3kflA:41.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X1L_A_ADNA601_1 (METHIONYL-TRNASYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 10 / 11 | ALA A 9ALA A 11HIS A 18GLY A 20HIS A 21GLU A 24GLY A 261ASP A 263ILE A 264HIS A 290 | ME8 A 801 ( 3.8A)ME8 A 801 (-3.1A)ME8 A 801 (-3.8A)ME8 A 801 (-3.6A)ME8 A 801 (-4.3A)ME8 A 801 (-3.6A)ME8 A 801 (-2.9A)ME8 A 801 (-3.1A)ME8 A 801 (-4.1A)ME8 A 801 (-4.7A) | 0.38A | 2x1lA-6ax8A:54.3 | 2x1lA-6ax8A:51.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X1L_A_ADNA601_1 (METHIONYL-TRNASYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 6 / 11 | GLY A 20HIS A 18GLY A 261ASP A 263ILE A 264HIS A 290 | ME8 A 801 (-3.6A)ME8 A 801 (-3.8A)ME8 A 801 (-2.9A)ME8 A 801 (-3.1A)ME8 A 801 (-4.1A)ME8 A 801 (-4.7A) | 1.09A | 2x1lA-6ax8A:54.3 | 2x1lA-6ax8A:51.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X1L_B_ADNB601_1 (METHIONYL-TRNASYNTHETASE) |
3kfl | METHIONYL-TRNASYNTHETASE (Leishmaniamajor) | 7 / 12 | HIS A 225GLY A 227HIS A 228GLY A 484ASP A 486ILE A 487HIS A 513 | POP A 802 ( 4.0A)ME8 A 801 (-3.4A)POP A 802 ( 3.8A)ME8 A 801 (-3.2A)ME8 A 801 ( 2.6A)ME8 A 801 (-4.0A)ME8 A 801 (-4.6A) | 0.50A | 2x1lB-3kflA:43.3 | 2x1lB-3kflA:41.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X1L_B_ADNB601_1 (METHIONYL-TRNASYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 11 / 12 | ALA A 9ALA A 11HIS A 18GLY A 20HIS A 21GLU A 24GLY A 261ASP A 263ILE A 264HIS A 290LEU A 293 | ME8 A 801 ( 3.8A)ME8 A 801 (-3.1A)ME8 A 801 (-3.8A)ME8 A 801 (-3.6A)ME8 A 801 (-4.3A)ME8 A 801 (-3.6A)ME8 A 801 (-2.9A)ME8 A 801 (-3.1A)ME8 A 801 (-4.1A)ME8 A 801 (-4.7A)ME8 A 801 (-4.5A) | 0.30A | 2x1lB-6ax8A:52.2 | 2x1lB-6ax8A:51.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X1L_B_ADNB601_1 (METHIONYL-TRNASYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 6 / 12 | GLY A 20HIS A 18GLY A 261ASP A 263ILE A 264HIS A 290 | ME8 A 801 (-3.6A)ME8 A 801 (-3.8A)ME8 A 801 (-2.9A)ME8 A 801 (-3.1A)ME8 A 801 (-4.1A)ME8 A 801 (-4.7A) | 1.08A | 2x1lB-6ax8A:52.2 | 2x1lB-6ax8A:51.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X1L_C_ADNC601_1 (METHIONYL-TRNASYNTHETASE) |
3kfl | METHIONYL-TRNASYNTHETASE (Leishmaniamajor) | 7 / 11 | HIS A 225GLY A 227HIS A 228GLY A 484ASP A 486ILE A 487HIS A 513 | POP A 802 ( 4.0A)ME8 A 801 (-3.4A)POP A 802 ( 3.8A)ME8 A 801 (-3.2A)ME8 A 801 ( 2.6A)ME8 A 801 (-4.0A)ME8 A 801 (-4.6A) | 0.50A | 2x1lC-3kflA:43.0 | 2x1lC-3kflA:41.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X1L_C_ADNC601_1 (METHIONYL-TRNASYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 10 / 11 | ALA A 9ALA A 11HIS A 18GLY A 20HIS A 21GLU A 24GLY A 261ASP A 263ILE A 264HIS A 290 | ME8 A 801 ( 3.8A)ME8 A 801 (-3.1A)ME8 A 801 (-3.8A)ME8 A 801 (-3.6A)ME8 A 801 (-4.3A)ME8 A 801 (-3.6A)ME8 A 801 (-2.9A)ME8 A 801 (-3.1A)ME8 A 801 (-4.1A)ME8 A 801 (-4.7A) | 0.30A | 2x1lC-6ax8A:52.0 | 2x1lC-6ax8A:51.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X1L_C_ADNC601_1 (METHIONYL-TRNASYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 6 / 11 | GLY A 20HIS A 18GLY A 261ASP A 263ILE A 264HIS A 290 | ME8 A 801 (-3.6A)ME8 A 801 (-3.8A)ME8 A 801 (-2.9A)ME8 A 801 (-3.1A)ME8 A 801 (-4.1A)ME8 A 801 (-4.7A) | 1.09A | 2x1lC-6ax8A:52.0 | 2x1lC-6ax8A:51.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JWQ_D_VIAD901_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASECATALYTIC DOMAIN,CONE CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASESUBUNIT ALPHACHIMERA) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 5 / 11 | ARG A 33HIS A 290ALA A 11LEU A 84GLN A 81 | NoneME8 A 801 (-4.7A)ME8 A 801 (-3.1A)NoneNone | 1.49A | 3jwqA-6ax8A:undetectable3jwqD-6ax8A:undetectable | 3jwqA-6ax8A:12.383jwqD-6ax8A:12.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UZZ_B_ASDB501_1 (3-OXO-5-BETA-STEROID4-DEHYDROGENASE) |
3kfl | METHIONYL-TRNASYNTHETASE (Leishmaniamajor) | 4 / 8 | TYR A 450HIS A 306TRP A 495LEU A 444 | ME8 A 801 (-4.7A)NoneNoneNone | 1.38A | 3uzzB-3kflA:undetectable | 3uzzB-3kflA:21.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BLV_A_SAMA1281_1 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE J) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 4 / 6 | HIS A 51HIS A 99ASP A 129ASP A 49 | NoneNoneNoneME8 A 801 (-4.1A) | 1.31A | 4blvA-6ax8A:undetectable | 4blvA-6ax8A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IG1_A_ACTA504_0 (FAD:PROTEIN FMNTRANSFERASE) |
3kfl | METHIONYL-TRNASYNTHETASE (Leishmaniamajor) | 4 / 5 | SER A 512ARG A 401LEU A 488ASP A 486 | NoneNoneEDO A 815 (-4.5A)ME8 A 801 ( 2.6A) | 1.32A | 4ig1A-3kflA:undetectable | 4ig1A-3kflA:21.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HG0_A_SAMA301_0 (PANTOTHENATESYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 5 / 12 | HIS A 18GLY A 20VAL A 227GLY A 261ASP A 263 | ME8 A 801 (-3.8A)ME8 A 801 (-3.6A)NoneME8 A 801 (-2.9A)ME8 A 801 (-3.1A) | 0.99A | 5hg0A-6ax8A:5.8 | 5hg0A-6ax8A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HG0_B_SAMB301_0 (PANTOTHENATESYNTHETASE) |
3kfl | METHIONYL-TRNASYNTHETASE (Leishmaniamajor) | 5 / 12 | HIS A 225GLY A 227HIS A 228VAL A 442ASP A 486 | POP A 802 ( 4.0A)ME8 A 801 (-3.4A)POP A 802 ( 3.8A)NoneME8 A 801 ( 2.6A) | 0.96A | 5hg0B-3kflA:7.5 | 5hg0B-3kflA:19.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HG0_B_SAMB301_0 (PANTOTHENATESYNTHETASE) |
3kfl | METHIONYL-TRNASYNTHETASE (Leishmaniamajor) | 5 / 12 | HIS A 225GLY A 227HIS A 228VAL A 442GLY A 484 | POP A 802 ( 4.0A)ME8 A 801 (-3.4A)POP A 802 ( 3.8A)NoneME8 A 801 (-3.2A) | 0.67A | 5hg0B-3kflA:7.5 | 5hg0B-3kflA:19.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HG0_B_SAMB301_0 (PANTOTHENATESYNTHETASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 6 / 12 | HIS A 18GLY A 20HIS A 21VAL A 227GLY A 261ASP A 263 | ME8 A 801 (-3.8A)ME8 A 801 (-3.6A)ME8 A 801 (-4.3A)NoneME8 A 801 (-2.9A)ME8 A 801 (-3.1A) | 1.02A | 5hg0B-6ax8A:5.8 | 5hg0B-6ax8A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HWA_A_GCSA302_1 (CHITOSANASE) |
3kfl | METHIONYL-TRNASYNTHETASE (Leishmaniamajor) | 4 / 7 | THR A 301ASP A 256ASP A 445GLY A 259 | NoneME8 A 801 (-3.7A)NoneNone | 0.78A | 5hwaA-3kflA:undetectable | 5hwaA-3kflA:18.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HWA_A_GCSA302_1 (CHITOSANASE) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 4 / 7 | THR A 94ASP A 49ASP A 230GLY A 52 | NoneME8 A 801 (-4.1A)NoneNone | 0.95A | 5hwaA-6ax8A:undetectable | 5hwaA-6ax8A:16.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IWU_A_ERYA404_0 (MACROLIDE2'-PHOSPHOTRANSFERASE II) |
6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) | 5 / 12 | ILE A 260HIS A 268PHE A 332ALA A 27PHE A 183 | NoneME8 A 801 (-4.6A)NoneNoneNone | 1.44A | 5iwuA-6ax8A:undetectable | 5iwuA-6ax8A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6J20_A_GBQA1201_0 (SUBSTANCE-PRECEPTOR,ENDOLYSIN) |
3kfl | METHIONYL-TRNASYNTHETASE (Leishmaniamajor) | 5 / 12 | ASN A 221ILE A 487TYR A 450THR A 253PHE A 284 | POP A 802 (-3.3A)ME8 A 801 (-4.0A)ME8 A 801 (-4.7A)NoneNone | 1.46A | 6j20A-3kflA:undetectable | 6j20A-3kflA:20.58 |